Loading company…
Porsolt provides preclinical testing and research services for drug development.
Founded in France in 1999, Porsolt provides physiopathological models, customized procedures, and preclinical testing services for drug development. Its capabilities cover areas including pain, oncology, toxicity, inflammation, dermatology, metabolic disorders, and central nervous system research. In February 2023, Apax Partners France and the company’s management acquired a majority stake.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in